Anteris Technologies Ltd
AMEUF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$125.66M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $125.66 Million |
|---|---|
| Enterprise Value | $-128,072,391.00 |
| Earnings per Share | $-6.09 |
| Beta | 0.75 |
| Outstanding Shares | 22,045,288 |
Return
| Return on Equity | -71.69% |
|---|---|
| Return on Assets | -66.13% |
| Return on Invested Capital | -72.37% |
Valuation & Multiples
| P/E Ratio | -2.39 |
|---|---|
| PEG | -0.85 |
| Price to Sales | - |
| Price to Book Ratio | 0.52 |
| Enterprise Value to Revenue | 134.35 |
| Enterprise Value to EBIT | -3.29 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Anteris Technologies Ltd
174 employees
CEO: Wayne Geoffrey Paterson
Anteris Technologies Ltd is a firm specializing in the structural heart domain. It is responsible for the production and distribution of ADAPT, a product based on regenerative tissue technology. The company is also actively involved in a...